IM Cannabis Corp. (IMCC)
| Market Cap | 795.34K -95.5% |
| Revenue (ttm) | 36.47M -6.5% |
| Net Income | -9.94M |
| EPS | -2.01 |
| Shares Out | 6.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 191,829 |
| Open | 0.1313 |
| Previous Close | 0.1300 |
| Day's Range | 0.1260 - 0.1325 |
| 52-Week Range | 0.0971 - 2.8300 |
| Beta | 2.11 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |
About IMCC
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Financial Performance
In 2025, IM Cannabis's revenue was 54.73 million, an increase of 1.30% compared to the previous year's 54.03 million. Losses were -11.32 million, 6.93% more than in 2024.
Financial numbers in CAD Financial StatementsNews
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
TORONTO and GLIL YAM, Israel, Aug. 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced ...
IM Cannabis Provides Corporate Update
TORONTO and GLIL YAM, Israel, July 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that ...
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
TORONTO and GLIL YAM, Israel, July 1, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, today announced ...
IM Cannabis signs LoI to sell European activities
IM Cannabis (IMCC) has entered into a non-binding letter of intent with Slil.com Holding Ltd., a privately-held Israeli entity beneficially owned and controlled by Oren Shuster, the company’s CEO, a…
IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million
Transaction Expected to Streamline Operations, Retain Israeli Business, Improve Working Capital through debt reduction and Cash Flow While Enabling the Pursuit of New Investment Opportunities as Previ...
IM Cannabis Announces Form F-3 Resale Registration Statement Filing
TORONTO and GLIL YAM, Israel, June 9, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, ...
IM Cannabis registers to sell 17.28M common shares for holders
This filing relates to the offer and sale from time to time by the selling stockholder of up to 17.28M common shares. The company is not selling any shares under…
IM Cannabis Registration statement: Registration filing
IM Cannabis filed a registration statement on June 9, 2026, providing details about a securities offering with the SEC.
IM Cannabis Corp. Announces First Quarter 2026 Financial Results
TORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced ...
IM Cannabis Earnings release: Q1 2026
IM Cannabis released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings
TORONTO and GLIL YAM, Israel, May 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced t...
IMC Announces Receipt of Nasdaq Minimum Bid Price Notification
TORONTO and GLIL YAM, Israel, April 10, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announce...
IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow
TORONTO and GLIL YAM, Israel, March 31, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today reported...
IM Cannabis Earnings release: Q4 2025
IM Cannabis released its Q4 2025 earnings on March 30, 2026, summarizing the period's financial results.
IM Cannabis Annual report: Q4 2025
IM Cannabis has published its Q4 2025 annual report on March 30, 2026.
Avant Brands issues notice of termination for agreement with Adjupharm
Avant Brands (AVBTF)’ wholly-owned subsidiary, GreenTec Holdings, has issued a formal notice of termination for its Trademark Licensing Agreement with Adjupharm, a subsidiary of IM Cannabis (IMCC) Cor...
IM Cannabis enters non-binding LOI to acquire 51% of Blackaxe Technologies
IM Cannabis (IMCC) announced that, following its previous announcement regarding its decision to explore the introduction of additional business activities, it has entered into a non-binding letter of...
IMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe Technologies
TORONTO and GLIL YAM, Israel, March 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, today announce...
IM Cannabis files to sell 9.79M common shares for holders
16:48 EST IM Cannabis (IMCC) files to sell 9.79M common shares for holders
IM Cannabis Registration statement: Registration Filing
IM Cannabis filed a registration statement on February 5, 2026, providing details about a securities offering with the SEC.
IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements
TORONTO and GLIL YAM, Israel, Jan. 26, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today a...
IM Cannabis announces appointment of Dayan to Board of Directors
IM Cannabis (IMCC) announced that Alon Dayan has been appointed to the Company’s board of directors effective December 31, 2025. Dayan is currently the Chief Executive Officer of KeepZone AI,…
IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors
TORONTO and GLIL YAM, Israel, Jan. 5, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), medical cannabis company with operations in Israel and Germany, announced today th...
IM Cannabis actively evaluating opportunities to expand operations into U.S.
IM Cannabis (IMCC) announced that it is actively evaluating certain strategic opportunities to expand its operations into the United States cannabis market. This initiative follows President Donald Tr...
IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research
Engages Exclusive Financial Advisors for U.S. Opportunities and Potential Divestitures of German and Israeli Operations TORONTO and GLIL YAM, Israel, Dec. 30, 2025 /PRNewswire/ -- IM Cannabis Corp. ("...